Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
October 13 2020 - 6:15AM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For
the month of October 2020
Alterity
Therapeutics Limited
(Name
of Registrant)
Level
3, 460 Bourke Street, Melbourne, VIC 3000, Australia
(Address
of Principal Executive Office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form
40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
Indicate
by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information
to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes
☐ No
☒
If
“Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-
_____
This
Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-248980 and 333-228671)
and our Registration Statements on Form F-3 (Files No. 333-249311 and 333-231417).
Alterity Therapeutics Limited
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
ALTERITY THERAPEUTICS LIMITED
|
|
|
(Registrant)
|
|
|
|
|
By:
|
/s/ Geoffrey Kempler
|
|
|
Geoffrey Kempler,
|
|
|
Executive Chairman
|
October 12, 2020
2
Alterity Therapeutics (NASDAQ:ATHE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Alterity Therapeutics (NASDAQ:ATHE)
Historical Stock Chart
From Sep 2023 to Sep 2024